Utility of early testing for HCV viremia as predictive factor of sustained response during interferon or interferon plus ribavirin treatment
- 1 May 2000
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 32 (5) , 843-849
- https://doi.org/10.1016/s0168-8278(00)80255-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cellsHepatology, 1998
- Hepatitis CThe Lancet, 1998
- Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparisonHepatology, 1997
- Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis CGastroenterology, 1997
- Treatment of chronic hepatitis C with interferon-α by monitoring the response according to viraemiaJournal of Viral Hepatitis, 1997
- The Treatment of Chronic Viral HepatitisNew England Journal of Medicine, 1997
- Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serumJournal of Hepatology, 1996
- Genotype, slow decrease in virus titer during interferon treatment and high degree of sequence variability of hypervariable region are indicative of poor response to interferon treatment in patients with chronic hepatitis type CJournal of Hepatology, 1995
- Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-αHepatology, 1992
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989